A. Norton

851 total citations
13 papers, 628 citations indexed

About

A. Norton is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A. Norton has authored 13 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 1 paper in Surgery. Recurrent topics in A. Norton's work include Occupational and environmental lung diseases (5 papers), Pleural and Pulmonary Diseases (4 papers) and Lung Cancer Research Studies (4 papers). A. Norton is often cited by papers focused on Occupational and environmental lung diseases (5 papers), Pleural and Pulmonary Diseases (4 papers) and Lung Cancer Research Studies (4 papers). A. Norton collaborates with scholars based in United Kingdom, Australia and New Zealand. A. Norton's co-authors include K. Priest, Ian E. Smith, S. Ashley, Mary O’Brien, Tim Eisen, Paul J. Ross, Justin S. Waters, E O’Brien, S. Ashley and Gary Middleton and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Australian Veterinary Journal.

In The Last Decade

A. Norton

12 papers receiving 595 citations

Peers

A. Norton

PRM

PHYSI

ONCOL

Sabine Wächter Germany

Satoshi Hamauchi Japan

Diclehan Ünsal Türkiye

Tomoko Jogo Japan

Wenyang Pang China

Massimiliano Salati Italy

Norberto Batista Spain

Breton Roussel United States

Ryuichi Karashima Japan

Sabine Wächter Germany

A. Norton

80 ×0.3

PRM

147 ×0.6

PHYSI

180 ×1.0

ONCOL

69 ×0.9

59 ×0.9

Citations per year, relative to A. Norton A. Norton (= 1×) peers Sabine Wächter

Countries citing papers authored by A. Norton

Since Specialization

Citations

This map shows the geographic impact of A. Norton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Norton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Norton more than expected).

Fields of papers citing papers by A. Norton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Norton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Norton. The network helps show where A. Norton may publish in the future.

Co-authorship network of co-authors of A. Norton

This figure shows the co-authorship network connecting the top 25 collaborators of A. Norton. A scholar is included among the top collaborators of A. Norton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Norton. A. Norton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Norton, A., et al.. (2024). Comparative analysis of racing performance following surgical correction of epiglottic entrapment in standardbreds and thoroughbreds. Frontiers in Veterinary Science. 11.

Norton, A., et al.. (2023). Use of intralesional cisplatin to successfully treat distal limb haemangiosarcoma in a foal. Australian Veterinary Journal. 101(8). 308–312. 2 indexed citations

O’Brien, Mary, T.K. Yau, Jermaine Coward, et al.. (2008). Time and Chemotherapy Treatment Trends in the Treatment of Elderly Patients (Age ≥ 70 Years) with Non-small Cell Lung Cancer. Clinical Oncology. 20(2). 142–147. 7 indexed citations

O’Brien, E, David Watkins, K. Priest, et al.. (2005). A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial. Annals of Oncology. 17(2). 270–275. 84 indexed citations

Yau, Thomas, S. Ashley, Sanjay Popat, et al.. (2005). Time and chemotherapy treatment trends in the treatment of elderly patients (age ⩾70 years) with small cell lung cancer. British Journal of Cancer. 94(1). 18–21. 19 indexed citations

Ross, Paul J., S. Ashley, A. Norton, et al.. (2004). Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. British Journal of Cancer. 90(10). 1905–1911. 353 indexed citations

Andreopoulou, Eleni, Paul J. Ross, Mary O’Brien, et al.. (2004). The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma. Annals of Oncology. 15(9). 1406–1412. 33 indexed citations

Mendes, R., Mary O’Brien, Abhishek Mitra, et al.. (2002). Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma. British Journal of Cancer. 86(3). 336–341. 18 indexed citations

Gregory, R.K., Ian E. Smith, A. Norton, S. Ashley, & Mary O’Brien. (2001). Mitomycin C, Vinblastine and Carboplatin: Effective Outpatient Chemotherapy for Advanced Non-Small Cell Carcinoma of the Lung (NSCLC). Clinical Oncology. 13(6). 483–487. 2 indexed citations

10.

Murray, P., Thierry Soussi, Mary O’Brien, et al.. (2000). Serum p53 antibodies: predictors of survival in small-cell lung cancer?. British Journal of Cancer. 83(11). 1418–1424. 26 indexed citations

11.

Middleton, Gary, Ian E. Smith, E O’Brien, et al.. (1998). Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. Annals of Oncology. 9(3). 269–273. 68 indexed citations

12.

Norton, A.. (1997). Nursing pay rates continue to widen.. PubMed. 3(8). 12–12. 1 indexed citations

13.

Karmiris, Efthymios, A. Z. S. Rohatiner, Sharon Love, et al.. (1994). The management of chronic lymphocytic leukemia at a single centre over a 24‐year period: prognostic factors for survival. Hematological Oncology. 12(1). 29–39. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact